What is a Generic Medication?. The World Health Organization Definition of a Generic Medication A generic drug is a pharmaceutical product, usually intended.

Slides:



Advertisements
Similar presentations
Fundamentals of Pharmacology for Veterinary Technicians
Advertisements

Patent-Extender Drugs: Loop-holes in the Law Sandy H. Yoo 4/14/06.
Bioequivalence Studies Anoop Agarwal
MeTa, Solwezi 27 August,2013.  A branded- name drug product is originally discovered and developed by a pharmaceutical company.  Branded-name drugs.
© Frommer Lawrence & Haug LLP BIOSIMILARS: ALTERNATIVE REGULATORY PATHWAYS American Conference Institute FOLLOW-ON BIOLOGICS June 22, 2010 Charles J. Raubicheck.
UNITED SPINAL ASSOCIATION AUGUST, 2014 Biologics & Biosimilars: An Overview 1.
Clinical Trials — A Closer Look. The Food and Drug Administration (FDA) is the main consumer watchdog for numerous products: Drugs and biologics (prescription.
Kyiv, TRAINING WORKSHOP ON PHARMACEUTICAL QUALITY, GOOD MANUFACTURING PRACTICE & BIOEQUIVALENCE Introduction to the Discussion of Bioequivalence.
The Global Generic Medications Market
Pharmacology Application in Athletic Training Michelle Odai, MS, LAT, ATC, CSCS Florida International University.
FEDERAL REGULATIONS OF MEDICATIONS Food, Drug and Cosmetic Act Protect consumers from adulterated and misbranded foods, drugs, cosmetics, or devices.
Development and Review Process of NDA, ANDA/AADA and OTC Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Associate Professor Department of Pharmaceutics KLE.
Bioavailability and Bioequivalence
N  What you are giving…  Why you are giving it…  Desired effect of the drug…  Possible side effects…  Appropriate dose range…  Potential interactions.
Artemisinin combined medicines, Kampala, February |1 | Training workshop on regulatory requirements for registration of Artemisinin based combined.
Regulation of Generic Drugs Office of Generic Drugs Craig Kiester Regulatory Support Branch.
AND GENERIC DRUGS BRAND-NAME AND GENERIC DRUGS WHAT TO CHOOSE? Natalia VEZIKOVA, MD, PhD, Natalia VEZIKOVA, MD, PhD, MSc The Head of the Hospital Therapy.
1 FDA Thailand By HIV Module/Marketing Group Mr. Manaswee Arayasiri.
WHO Prequalification Program Workshop, Kiev, Ukraine, June 25-27,2007.
Generic Substitution Principles in Practice Copyright © – Academy of Managed Care Pharmacy (AMCP)Slide 1.
Documentation of bioequivalence Drs. J. Welink Workshop on WHO prequalification requirements for reproductive health medicines, Jakarta, October 2009.
Bioequivalence Studies Dr Sanet Aspinall, PhD Managing Director AddClin Research Pretoria 20 March 2009.
What You Want to Know About Generic Drugs Generic Drugs: Safe. Effective. FDA-Approved.
Subsequent Entry Biologics (SEBs) – Canada Presentation to AIPLA Biotechnology Committee January 25, 2012 Daphne C. Lainson
VETERINARY DRUG USE AND PRESCRIBING CH. 5. –All drugs have 3 names Chemical name Generic (nonproprietary) name Trade (proprietary) name.
A substance used in the diagnosis, treatment, or prevention of a disease or as a component of a medication A substance used in the diagnosis, treatment,
Generic Substitution of AEDs: Is There Cause for Concern? Barry E. Gidal, PharmD Professor of Pharmacy and Neurology University of Wisconsin School of.
CHEE DRUG PRODUCT DEVELOPMENT u Drug ä agent intended for use in the diagnosis, mitigation, treatment, cure, or prevention of disease in man or animals.
Week 6- Bioavailability and Bioequivalence
Dietary Supplements. Definition by DSHEA Product that is to supplement a healthy diet. Includes ingredients such as vitamins, minerals, herbs, botanicals,
FDA Focus On Consumer Protection
ACPS Meeting, October 19-20, 2004 BioINequivalence: Concept and Definition Lawrence X. Yu, Ph. D. Director for Science Office of Generic Drugs, OPS, CDER,
Marcel H.N. Hoefnagel 2 November 2007 BIOSIMILARS are not Generics But similar.
WHO Workshop on Prequalification of Medicines Programme, Abu Dhabi, October, 2010 Regulatory principles reflected in practice of WHO PQP Milan Smid,
The New Drug Development Process (www. fda. gov/cder/handbook/develop
The FDA: Basic Facts It takes 12 to 15 years to develop a single drug Only 1 in 10,000 potential medications makes it completely through the process Only.
Bioequivalence of Locally Acting Gastrointestinal Drugs: An Overview
CHEE 4401 Definitions drug - any substance that affects the structure or functioning of an organism pharmaceutics - the area of study concerned with the.
Copyright © 2010 by K&L Gates LLP. All rights reserved. The Biosimilars Act—A Basic Introduction Michael H. Hinckle K&L Gates Research Triangle Park, NC.
Bioavailability Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Department of Pharmaceutics Faculty of Pharmacy Omer Al-Mukhtar University Tobruk, Libya.
Using Product Development Information to Address the Bioequivalence Challenges of Highly-variable Drugs Lawrence X. Yu, Ph. D. Director for Science Office.
“Journey of a Drug” From Test Tube TO Prescribing Physician.
Malaysia, EVALUTION OF DOSSIERS IN WHO- PREQUALIFICATION PROJECT MULTISOURCE TB-DRUGS Evaluation of bioavailability/bioequivalence data Based,
Bioavailability and Bioequivalence L 10,11.  Bioavailability is a measurement of the rate and extent (amount) to which the active ingredient or active.
GMP- A Regulatory Perspective. Regulatory Perspective in entering Global Pharma Markets.
Drug Regulation, Development, Names, and Information Chapter 3 Copyright (c) 2004 Elsevier Inc. All rights reserved.
Equivalence pharmaceutical equivalents---drugs must have same active ingredients, in same strength, in same dosage form, same RofA. Inactive ingredients.
Copyright 2010, Morgan, Lewis & Bockius LLP Healthcare Reform--New Path for Biosimilars Kathleen M. Sanzo, Esq. Washington, DC May.
Topic #2: Quality by Design and Pharmaceutical Equivalence Ajaz S. Hussain, Ph.D. Office of Pharmaceutical Science Center for Drug Evaluation and Research.
 An Abbreviated New Drug Application (ANDA) contains data which when submitted to FDA's CDER, Office of Generic Drugs, provides for the review and ultimate.
OVER THE COUNTER MEDS INTRODUCTION No prescriptions are necessary and no questions need to be answered to attain these drugs OTC med use saves.
Regulation of Generic Animal Drugs in the United States
1 Structured Product Labeling Project Update Randy Levin, M.D. Director for Health and Regulatory Data Standards Food and Drug Administration HL7 Working.
Emerging Health Care Issues: The U.S. FTC Report on Follow-on Biologic Drug Competition Sue H. Kim Foreign Attorney Yoon & Yang LLC.
A substance used in the diagnosis, treatment, or prevention of a disease or as a component of a medication recognized or defined by the U.S. Food, Drug,
The process of drug development. Drug development 0,8 – 1 mld. USD.
Pharmacology Science that studies interactions of drugs with organism on different levels (subcellular, cellular, organ, systemic) Studies: - relationship.
Difference to Generics What can they do for us in the future
BASICS IN PHARMA.
Clinical Trials — A Closer Look
Generic Medicines.
CHAWLA MEDICOS Present’s Branded v/s Generic medicine
9.4 Product Quality Control
Percentage Key Message
Clinical Pharmacokinetics
EMA: The European Medicines Agency
Insight into the Pharmaceutical Industry
Prescription vs. OTC.
Presentation transcript:

What is a Generic Medication?

The World Health Organization Definition of a Generic Medication A generic drug is a pharmaceutical product, usually intended to be interchangeable with an innovator product, that is manufactured without a licence from the innovator company and marketed after the expiry date of the patent or other exclusive rights. Source World Health Organization, accessed

What is a Generic Medication? A generic drug is identical -- or bioequivalent -- to a brand name drug in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use. Source: US Food and Drug Administration questionsanswers/ucm htm, accessed

What is a Generic Medication? Generic drugs are marketed under a non-proprietary or approved name rather than a proprietary or brand name. For example, paracetamol is a chemical ingredient found in a number of brand-name painkillers, but is also sold as a generic drug (not under a brand name). Source World Health Organization, accessed

What Are the Advantages of a Generic Medication? Although generic drugs are chemically identical to their branded counterparts, they are typically sold at substantial discounts from the branded price. Cost to the consumer is typically 20% to 90% less than the brand-name original with the same safety, quality and efficacy. Source: US Food and Drug Administration questionsanswers/ucm htm,accessed

What is the Primary Driver to Reducing the Cost of Generic Medications? Generic drugs do not have to undergo the large, expensive clinical trials that are required for approval of brand-name medications. Strict standards exist to guarantee the quality of generic drugs through a process known as an abbreviated new drug application (ANDA), and bioequivalence studies. Source: Pawel Lewek and Przemyslaw Kardas, The Journal of Family Practice, Vol 59 No. 11, 2010

The active pharmaceutical ingredient (API) is the chemical that has the desired biological effect in a medication and is the same in both branded and generic medications. The ANDA process does not require costly animal and clinical research on ingredients or dosage forms already approved for safety and effectiveness /09/WC pdfhttp:// 009/09/WC pdf Accessed How is a Generic Medication Determined Equivalent to Brand Name Drug?

Therapeutic equivalence of a generic drug is based on pharmacokinetic parameters, most notably, the area under the plasma concentration curve (AUC)—a measure of overall drug exposure—and the maximal plasma concentration (Cmax). The process for new generic medication approval is clear, following a well-defined roadmap 009/09/WC pdfhttp:// 009/09/WC pdf Accessed

Setting the Bar for Successful Approval: Standards for Generic Medications 1. Contain the same active ingredients as the innovator drug (inactive ingredients may vary) 2. Identical in treatment indications, strength, dosage form, route of administration and bioequivalence 3. Meet the same batch requirements for identity, strength, purity, and quality 4. Manufactured under the same strict standards of FDA and EMA good manufacturing practice regulations required for innovator products Source: US Food and Drug Administration questionsanswers/ucm htm, accessed

Summary Generic drugs offer identical quality, benefit and safety when compared to branded medications, with significant cost savings for product development and to the consumer.